In brief, mRNA expression profiling of candidate genes in each locus was performed using semi-quantitative RT-PCR in a panel of ESCC and NPC cell lines, normal tissues and immortalized epithelial cell lines. Genes downregulated in cancer cells but with high expression in normal tissues and immortalized epithelial cells were subjected to promoter methylation analysis using methylation-specific PCR (MSP), bisulfite genomic sequencing (BGS) and pharmacological demethylation treatment. Genes with tumor-specific downregulation and methylation were further selected as candidates and their tumor suppressive roles were verified via functional studies. / In conclusion, RAB39 and WDRX, epigenetically silenced in multiple cancer cell lines, were identified as novel TSG candidates in this study. Meanwhile, the tumor suppressive functions of ADAMTS8 were further validated, proving the efficiency of this integrative approach. Further study on these novel TSG candidates may help to elucidate the detailed molecular mechanisms for ESCC and NPC, and provide novel therapeutic targets and biomarkers. / In this study, RAB39 and WDRX were identified as candidate TSGs in 11q22.3 and 15q21.3, respectively. Both genes were broadly expressed in normal tissues and immortalized epithelial cell lines, but significantly downregulated and methylated in multiple cancer cell lines. Demethylation treatment with 5-Aza-2'-deoxycytidine restored their mRNA expression, indicating that CpG methylation directly contributed to their transcriptional inactivation. Methylation of RAB39 and WDRX was detected in primary ESCC and NPC, but rarely observed in normal tissues, implicating that their tumor-specific methylation might be used as biomarkers. Ectopic expression of both genes significantly inhibited the clonogenicity of multiple cancer cell lines, supporting their potential roles as functional TSGs. Moreover, WDRX repressed WNT/beta-catenin signaling, underscoring a possible anti-tumorigenic mechanism for it. In addition, ADAMTS8 was revealed to inhibit clonogenicity of NPC and ESCC cell lines, acting as a negative modulator for ERK pathway and a potential pro-apoptotic metalloprotease. / Inactivation of tumor suppressor genes (TSGs) contributes to the genesis of cancers including esophageal squamous cell carcinoma (ESCC) and nasopharyngeal carcinoma (NPC), two prevalent causes of death in Hong Kong. Apart from genetic abnormalities, epigenetic disruptions including CpG methylation represent another major mechanism for TSG inactivation. Promoter methylation of multiple TSGs was detected in different cancer types, suggesting that it could be utilized as therapeutic target or biomarker for disease diagnosis and prognosis. / TSGs are often located at frequently deleted chromosomal regions and subjected to tumor-specific methylation, making it possible to use an integrative epigenetic and genomic approach combining array comparative genomic hybridization (aCGH) with epigenetic profiling to screen for novel TSGs. Previous aCGH revealed that several loci in 11822.3, 15q14, 15q21.1 and 15q21.3 underwent frequent copy number loss in ESCC cell lines. Loss of heterozygosity (LOH) of these regions was also reported in other cancers, indicating that TSGs might reside within them. The aim of this study was thus to identify the candidate TSGs in these loci and study their anti-tumorigenic roles. In addition, the tumor suppressive function of ADAMTS8, a silenced 11q25 candidate TSG previously identified in our lab via this approach, was also studied. / Li, Jisheng. / Adviser: Qian Tao. / Source: Dissertation Abstracts International, Volume: 72-04, Section: B, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2010. / Includes bibliographical references (leaves 136-159). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. Ann Arbor, MI : ProQuest Information and Learning Company, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.

Wong, Ho Ting. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references (leaves 66-77). / Abstracts in English and Chinese. / Acknowledgement --- p.i / List of abbreviations --- p.ii / List of tables and figures --- p.iv / Abstract in English --- p.vi / Abstract in Chinese --- p.viii / Table of content --- p.x / Chapter Chapter 1 --- Literature review / Chapter 1.1 --- Nasopharyngeal carcinoma (NPC) and treatments --- p.1 / Chapter 1.2 --- EBV and NF-kB signaling in NPC / Chapter 1.2.1 --- Role of EBV and NF-kB in NPC --- p.2 / Chapter 1.2.2 --- NF-kB signaling in cancer --- p.4 / Chapter 1.2.3 --- NF-kB activation in NPC --- p.7 / Chapter 1.2.3.1 --- NF-kB activation by LMP1 --- p.8 / Chapter 1.2.3.2 --- NF-kB and LMP2A --- p.10 / Chapter 1.2.3.3 --- NF-kB activation by non-viral factors --- p.10 / Chapter 1.2.4 --- NF-kB target genes in NPC --- p.11 / Chapter 1.3 --- NF-kB targeting / Chapter 1.3.1 --- NF-kB targeting agents --- p.14 / Chapter 1.3.2 --- "DHMEQ, a novel blocker of NF-kB Transactivation" --- p.15 / Chapter Chapter 2 --- Aim of study and Research plan --- p.18 / Chapter Chapter 3 --- Materials and Methods / Chapter 3.1 --- Cell lines and Reagents --- p.20 / Chapter 3.2 --- Cell viability assay --- p.21 / Chapter 3.3 --- Cell apoptosis detection / Chapter 3.3.1 --- PARP cleavage --- p.22 / Chapter 3.3.2 --- DNA fragmentation --- p.22 / Chapter 3.4 --- Cell cycle analysis --- p.22 / Chapter 3.5 --- Transwell migration or Matrigel invasion assay --- p.23 / Chapter 3.6 --- Soft agar colony formation assay --- p.24 / Chapter 3.7 --- Drug treatment for western blotting --- p.25 / Chapter 3.8 --- "Protein extraction and quantification, SDS-PAGE and western blotting" / Chapter 3.8.1 --- Protein extraction and quantification --- p.25 / Chapter 3.8.2 --- SDS-PAGE and western blotting --- p.26 / Chapter 3.9 --- Fractionation --- p.28 / Chapter 3.10 --- NF-kB transcriptional activity assay / Chapter 3.10.1 --- Construction of NF-kB reporter system --- p.29 / Chapter 3.10.2 --- Luciferase assay --- p.29 / Chapter 3.11 --- Statistical Analysis --- p.30 / Chapter Chapter 4 --- Results / Chapter 4.1 --- Anti-tumor activity of DHMEQ in NPC / Chapter 4.1.1 --- Growth inhibition in NPC cell lines --- p.31 / Chapter 4.1.2 --- Apoptotic induction in NPC cell lines --- p.35 / Chapter 4.1.3 --- Cell cycle arrest in NPC cell lines --- p.38 / Chapter 4.1.4 --- Inhibition of migration and invasive behavior of NPC cell lines --- p.38 / Chapter 4.1.5 --- Abrogation of soft agar colony formation ability of NPC cell lines --- p.43 / Chapter 4.2 --- Mechanistic study of DHMEQ in NPC / Chapter 4.2.1 --- Blockade of p65 nuclear translocation --- p.48 / Chapter 4.2.2 --- Attenuation of NF-kB transcriptional activity --- p.48 / Chapter 4.2.3 --- Downregulation of NF-kB target genes --- p.53 / Chapter Chapter 5 --- Discussion --- p.54 / Chapter Chapter 6 --- Summary --- p.60 / Chapter Chapter 7 --- Future Study --- p.63 / Reference List --- p.66 / Appendix / Chapter Appendix 1 --- Construction of NF-kb report plasm id --- p.78 / Chapter Appendix 2 --- Wound healing assay --- p.86 / Chapter Appendix 3 --- Reverse-phase protein Array --- p.88

"Background: Nasopharyngeal carcinoma (NPC) is endemic in southern China. Despite the improvement in radiotherapy (RT) technology, NPC patients still suffer from numerous and simultaneous distressing symptoms. / Aims: The aim of the study was to explore the feasibility of an intervention program (an educational intervention program) in managing the most distressing symptom cluster (nutrition impact symptom cluster) in NPC patients during RT. / Methods: The study was carried out in two parts. Part I consisted of groundwork research (n = 130) using a cross-sectional design to identify the most distressing symptom cluster. An instrument validation was also conducted at this point. Part II covered the development process and pilot testing of an educational intervention program, guided by the Medical Research Council (MRC) framework, to manage the nutrition impact symptom cluster identified in Part I. First, to inform development of the intervention, a systematic review was conducted to evaluate the effectiveness of psychoeducational intervention (PEI), which includes the educational intervention, in managing symptom clusters in patients with generic cancers. Second, a descriptive qualitative study was conducted through face-to-face semi-structured interviews with 25 NPC patients and 16 health professionals, separately, to provide further help in developing the intervention by investigating patients’ self-care experience and current clinical practice in managing the nutrition impact symptom cluster. Third, the feasibility and estimated effectiveness of the educational intervention program was explored in a pilot randomized controlled trial (RCT) (n = 40). Outcome measures, including severity of the nutrition impact symptom cluster, body weight, functional performance and quality of life (QOL), were assessed at baseline, week 3 of RT and at the end of RT. Inferential statistics, such as independent t-test, Chi-square test, Fisher’s exact test and the generalized estimating equation (GEE) model, were used to compare the baseline and various outcome variables between groups. / Results: In Part I, the Chinese version of the MD Anderson Symptom Inventory - Head and Neck Module (MDASI-HN-C) was found to be a reliable and valid instrument. The same dataset then revealed four symptom clusters in NPC patients during RT; the nutrition impact cluster was identified as the most distressing, and was thus chosen as the target outcome of the intervention. In Part II, the systematic review found that PEI, in particular, patient education, was a promising intervention to manage cancer symptom clusters. Then, the findings of the qualitative study further informed and guided the development of an educational intervention program. The pilot RCT found that the conducting the program in a clinical setting was feasible and well received by patients. It also had some favorable effects on managing the nutrition impact symptom cluster, in terms of relieving the cluster itself (Cohen’s d = -0.37), and improving the physical well-being (Cohen’s d = -0.15) and head and neck cancer (HNC) specific QOL (Cohen’s d = -0.05). / Conclusion: The implementation of the educational intervention program appears to be feasible with NPC patients during RT, showing some effect in improving the nutrition impact symptom cluster. A future full-scale study with an adequate sample is warranted." / 研究背景：鼻咽癌在中國南部高發。儘管放療技術在進步，鼻咽癌病人在接受放療期間仍然存在著各種同時出現的症狀困擾。 / 研究目的：本研究旨在測試一個健康教育干預項目在管理鼻咽癌病人放療期間最嚴重的營養相關症狀群的可行性。 / 研究方法：本研究分為兩個部分。第一部分採用橫斷面的研究方法（n = 130），目的是為了找出最嚴重的症狀群，包括檢驗一個量表的信效度。第二部分包括健康教育干預專案的設計和預實驗。首先，研究者做了一個系統評價來評估心理及健康教育干預對管理癌症病人症狀群的效果。然後，研究者又做了一個質性研究，通過與25名鼻咽癌放療病人和16名醫護人員面對面訪談來瞭解目前營養相關症狀群的管理現狀，以便為干預的設計提供進一步線索。最後，研究者做了一個隨機對照試驗的預實驗（n = 40），來評價本研究所設計的健康教育干預專案的可行性。研究指標包括營養相關症狀群的嚴重性、體重、功能水準以及生活品質，並於干預前、放療第3周以及放療結束進行測量。統計推斷方法包括獨立樣本t檢驗、卡方檢驗、Fisher確切概率法和廣義估計方程模型，用以比較組間差異。 / 研究結果：第一部分的研究結果表明，中文版的M. D. Anderson症狀調查表（頭頸）的信效度良好。此外，四個症狀群被發現，其中以營養相關症狀群最為嚴重，因此被選為本研究的干預目標。第二部分，通過系統評價，研究者發現心理及健康教育干預，尤其是健康教育對管理癌症病人的症狀群有一定效果。接著，質性研究的結果進一步提示了健康教育干預項目的必要性，並為該專案的設計提供了具體方案。最後，預實驗表明本研究所設計的健康教育干預專案是可行的並受病人歡迎。該項目在減輕營養相關症狀群（Cohen’s d = -0.37）以及提高與身體（Cohen’s d = -0.15）和頭頸癌相關（Cohen’s d = -0.05）的生活品質上有一定效果。 / 研究結論：本研究所設計的健康教育干預專案是可行的，並對管理鼻咽癌病人放療期間的營養相關症狀群有一定效果。將來需要做一個大規模的研究來驗證該項目的有效性。" / Xiao, Wenli. / Thesis Ph.D. Chinese University of Hong Kong 2016. / Includes bibliographical references (leaves 226-250). / Abstracts also in Chinese. / Title from PDF title page (viewed on 01, February, 2018). / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only.

First, expression profiling of ZNFs with CpG islands at 10 clusters of Chr19 was examined in a panel of NPC and ESCC cell lines by semi-quantitative RT-PCR, with adult normal tissues - larynx and esophagus as controls. Several down-regulated genes were identified, and I further focused on 5 candidates: ZNF382, ZNF545, ZFP30, ZNFT1 and ZNFT2. These genes were frequently downregulated in NPC, ESCC, lung, gastric, colon and breast carcinomas. Their promoters were frequently methylated in multiple downregulated cell lines but less in non-tumor cell lines as revealed by methylation-specific PCR (MSP) and bisulfite genomic sequencing (BGS). Their expression could be restored by pharmacologic or genetic demethylation, suggesting that DNA methylation was directly involved in their silencing. The frequent methylation of these genes indicated they could act as potential biomarkers. / In conclusion, several novel candidate TSGs epigenetically silenced in tumor cells were identified in this study. Their downregulation by promoter methylation was tumor-specific, which could be use as epigenetic biomarkers for diagnosis. / More functional studies were done for ZNF382 and ZNF545, I found that ectopic expression of ZNF382 and ZNF545 in tumor cells lacking endogenous expression could inhibit tumor cell clonogenicity, proliferation and induce apoptosis. I found that ZNF382 suppressed tumorigenesis through mediating heterochromatin formation, as ZNF382 was revealed to be co-localized and interacts with heterochromatin protein. For ZNF545, I found that it is a transcriptional repressor. I further showed that ZNF545 was located in the nucleus and sequestered in the nucleolus. ZNF545 could inhibit tumorigenesis at least partially through downregulating the transcription of target genes or regulating nucleolus function such as ribosome biogenesis. / The development of a tumor from a normal cell is a complex and multi-step process. A large number of oncogenes, tumor suppressor genes (TSGs) and signal transduction pathways are involved in this process. Tumor-specific methylation of TSGs in multiple tumors indicated that it could be used as epigenetic biomarker for molecular diagnosis and therapeutics. / The functions of KRAB-containing proteins are critical to cell differentiation, proliferation, apoptosis and neoplastic transformation. A large number of ZNF genes are located in 10 clusters at chromosome 19. Some of the KRAB-ZNF may function as potential TSGs with epigenetic alterations. Thus, I try to identify silenced novel KRAB-ZNF candidate TSGs through screening chromosome 19. / Cheng, yingduan. / Adviser: Tao Qian. / Source: Dissertation Abstracts International, Volume: 73-02, Section: B, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2010. / Includes bibliographical references (leaves 110-136). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [201-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.

by Chiu Yuk Lan. / Thesis (M.Phil.)--Chinese University of Hong Kong, 1998. / Includes bibliographical references (leaves 127-133). / Abstract also in Chinese. / TABLE OF CONTENTS / ABSTRACT (ENGLISH) --- p.a / ABSTRACT (CHINESE) --- p.b / ACKNOWLEDGEMENTS --- p.iv / Chapter CHAPTER 1 --- INTRODUCTION --- p.1 / Chapter 1.1 --- Cancer in Food-service Workers --- p.1 / Chapter 1.2 --- Carcinogenicity of Cooking Fumes --- p.1 / Chapter 1.3 --- High Risk of Lung Cancer in Chinese Women --- p.2 / Chapter 1.4 --- Why do We Conduct This Study? --- p.3 / Chapter 1.5 --- Implication of This Study --- p.4 / Chapter 1.6 --- What Types of Cancer were Included in This Study? --- p.4 / Chapter 1.7 --- Aims and Hypothesis of This Study --- p.5 / Chapter 1.8. --- Outline of the Thesis --- p.5 / Chapter CHAPTER 2 --- LITERATURE REVIEW --- p.8 / Chapter 2.1. --- Occupational Epidemiological Studies --- p.8 / Chapter 2.1.1 --- Studies of occupation and cancer occurrence based on routine records --- p.8 / Chapter 2.1.2 --- Retrospective cohort studies among food service workers --- p.21 / Chapter 2.1.3 --- Case-control studies --- p.27 / Chapter 2.1.4 --- Case reports --- p.29 / Chapter 2.1.5 --- Summary --- p.29 / Chapter 2.2. --- Mutagens and Carcinogens in Cooking Fumes --- p.39 / Chapter 2.2.1 --- Mutagens and carcinogens in cooking fumes --- p.40 / Chapter 2.2.2 --- Summary --- p.42 / Chapter CHAPTER 3 --- METHODS --- p.44 / Chapter 3.1 --- Study Design --- p.44 / Chapter 3.2 --- Study Population and Subjects --- p.46 / Chapter 3.3 --- Reference Population --- p.48 / Chapter 3.4 --- Sample Size Estimation --- p.48 / Chapter 3.5 --- Data Sources and Data Collection --- p.49 / Chapter 3.6 --- Data Processing --- p.53 / Chapter 3.7 --- Data Analyses --- p.54 / Chapter 3.7.1 --- Standardised proportional mortality ratio (SPMR) --- p.54 / Chapter 3.7.2 --- Adjusted' SPMRs --- p.56 / Chapter 3.7.3 --- Mortality odds ratio (MOR) --- p.58 / Chapter 3.8. --- Exploring if Smoking could be a Confounding Factor --- p.62 / Chapter CHAPTER 4 --- RESULTS --- p.64 / Chapter 4.1 --- Characteristics of the Food-service Workers --- p.64 / Chapter 4.2 --- Cancer Mortality Patterns of Food-service Workers --- p.69 / Chapter 4.3 --- Adjusted SPMRs --- p.72 / Chapter 4.4 --- Mortality Odds Ratios (MORs) --- p.76 / Chapter 4.5 --- Mortality Odds Ratios Using Multiply Reference Diseases --- p.77 / Chapter 4.6. --- Comparing SPMRs with MORs --- p.82 / Chapter 4.7. --- Internal Comparison --- p.83 / Chapter 4.8 --- Summary of Results --- p.90 / Chapter 4.9. --- Survey on Smoking and Drinking Prevalence among Current Food-service Workers --- p.92 / Chapter 4.9.1 --- Smoking habit --- p.92 / Chapter 4.9.2 --- Drinking habit --- p.94 / Chapter CHAPTER 5 --- DISCUSSION OF FINDINGS --- p.95 / Chapter 5.1 --- Outcomes for This Study --- p.95 / Chapter 5.1.2 --- Cancer risks for the kitchen workers --- p.96 / Chapter 5.1.3 --- Cancer risks for the outside kitchen workers --- p.102 / Chapter 5.2 --- Limitations of the Methods Adopted in the Present study --- p.107 / Chapter 5.2.1 --- Standardised proportional mortality ratio (SPMR) --- p.107 / Chapter 5.2.2 --- Morality odds ratio (MOR) --- p.109 / Chapter 5.3 --- Bias and Control --- p.111 / Chapter 5.3.1 --- Selection bias --- p.111 / Chapter 5.3.2 --- Information bias --- p.113 / Chapter 5.3.3 --- Confounding --- p.116 / Chapter 5.4 --- Implications from the Results of the Present Study --- p.117 / Chapter 5.5 --- Conclusion --- p.119 / APPENDIX --- p.121 / Appendix 1 --- p.121 / Appendix 2 --- p.123 / Appendix 3 --- p.124 / Appendix 4 --- p.125 / REFERENCES --- p.127

Eighty-two patients with breast cancer, twenty-seven patients with nasopharyngeal carcinoma and sixty-five patients with rheumatoid arthritis in this study were selected based on voluntary, randomization and double blind grouping criteria. / In nasopharyngeal carcinoma patients, the decrease in percentage and the absolute count of T lymphocytes in the TCM group was significantly lower than those in the placebo group. Besides, the decrease of the absolute count of T helper and T suppressor in the TCM group was significantly lower than that in the placebo group (all p < 0.05). The decrease may be due to radiotherapy. However, there was no significant difference in plasma sIL-2R and soluble tumor necrosis factor receptor 2 (sTNFR2) between the TCM group and the placebo group. / In rheumatoid arthritis patients, there was no significant difference in plasma. C-reactive protein (CRP), in the percentage, absolute count, and the ratio of CD4+/CD8+/NK/B lymphocytes between the TCM group and the placebo group. / Results showed that the absolute count of T helper lymphocytes (CD4+), the ratio of T helper lymphocytes (CD4+)/T suppressor and cytotoxic lymphocytes (CD8+), and the percentage and the absolute count of B lymphocytes were significantly elevated in the patients with breast cancer after taking Yunzhi-Danshen capsules, while plasma soluble interleukin-2 receptor (sIL-2R) concentration was significantly decreased (all p < 0.05). / This study shows that the selected traditional Chinese medicine have determinable immunomodulatory effects in patients with cancer and rheumatoid arthritis. (Abstract shortened by UMI.) / Traditional Chinese medicine (TCM) has been used to treat chronic diseases and tumor allegedly by immunomodulatory mechanisms. Breast cancer and nasopharyngeal cancer are prevalent carcinoma diseases in Hong Kong. The immune system of such patients could be adversely affected during the course of conventional chemotherapy or radiotherapy. Rheumatoid arthritis is an inflammatory autoimmune disease of the joints. The aim of this study was to assess the immunomodulatory effects of TCM Yunzhi-Danshen in auxiliary treatment of both kinds of cancer patients, and Lingzhi (Ganoderma Lucidum)-San Miao San ( Atractylodes lancea, Phellodendron amurense and Achyranthes bidentata B1) in supplementation treatment of patients with rheumatoid arthritis. / by Bao Yixi. / "July 2005." / Adviser: Wai-Kei Lam. / Source: Dissertation Abstracts International, Volume: 67-01, Section: B, page: 0166. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2005. / Includes bibliographical references (p. 150-167). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts in English and Chinese. / School code: 1307.

Fong, Kwan Ying. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2010. / Includes bibliographical references (leaves 90-103). / Abstracts in English and Chinese. / Chapter Chapter 1: --- "Introduction, problems and objectives" --- p.1 / Chapter 1.1 --- Introduction --- p.1 / Chapter 1.2 --- Problems --- p.3 / Chapter 1.3 --- Objectives --- p.3 / Chapter Chapter 2: --- Background --- p.4 / Chapter 2.1. --- Head and Neck Cancer --- p.4 / Chapter 2.2 --- Diagnostic Imaging of Head and Neck Cancer --- p.5 / Chapter 2.3. --- Magnetic Resonance Imaging- Physics --- p.8 / Chapter 2.3.1 --- Nuclear Magnetic Resonance Principle --- p.8 / Chapter 2.3.2 --- Proton Magnetic Resonance Imaging --- p.8 / Chapter 2.3.3 --- Relaxation --- p.12 / Chapter 2.3.4 --- Tl- and T2-weighted Imaging --- p.12 / Chapter 2.3.5 --- Diffusion Weighted Imaging (DWI) --- p.13 / Chapter 2.3.6 --- Magnetic Resonance Spectroscopy- Single Voxel Spectroscopy and Chemical Shift Imaging --- p.15 / Chapter Chapter 3: --- Diffusion-weighted imaging in the evaluation head of and neck cancer --- p.21 / Chapter 3.1 --- Introduction - Diffusion-Weighted Imaging in Tumors --- p.21 / Chapter 3.2 --- DWI of Nasopharyngeal Carcinoma --- p.22 / Chapter 3.2.1 --- Introduction and Objectives --- p.22 / Chapter 3.2.2. --- Methods --- p.23 / Chapter 3.2.3. --- Results --- p.27 / Chapter 3.2.4 --- Discussion --- p.31 / Chapter 3.3 --- DWI of Primary Tumors: Comparison of NPC with Squamous Cell Carcinoma and Extra-nodal Non-Hodgkin Lymphoma --- p.33 / Chapter 3.3.1 --- Introduction and Objectives --- p.33 / Chapter 3.3.2. --- Methods --- p.34 / Chapter 3.3.3. --- Results --- p.35 / Chapter 3.3.4 --- Discussion --- p.42 / Chapter 3.3.5 --- Summary of DWI in Head and Neck Cancer --- p.44 / Chapter Chapter 4: --- Chemical shift imaging of head and neck tumors --- p.45 / Chapter 4.1 --- Introduction - Single Voxel Spectroscopy and Chemical Shift Imaging --- p.45 / Chapter 4.2 --- CSI - Methods Used to Reduce Magnetic Field Inhomogeneity --- p.48 / Chapter 4.3 --- Phantom studies - CSI Experiments Using Phantoms --- p.51 / Chapter 4.3.1 --- Introduction and Objectives --- p.51 / Chapter 4.3.2. --- Methods --- p.51 / Chapter 4.3.3 --- Experiment and MR Protocol --- p.54 / Chapter 4.3.4 --- Data Analysis --- p.58 / Chapter 4.3.5 --- Phantom Experimental Results --- p.59 / Chapter 4.3.6 --- Discussion and Conclusion on Phantom Experiments --- p.69 / Chapter 4.4 --- In vivo CSI Study of Human Head and Neck Tumors --- p.72 / Chapter 4.4.1 --- Introduction and Objectives --- p.72 / Chapter 4.4.2 --- Patient Selection --- p.73 / Chapter 4.4.3 --- MRI and CSI Protocol --- p.73 / Chapter 4.4.4 --- Data Analysis --- p.74 / Chapter 4.4.5 --- Results from CSI on Patients --- p.74 / Chapter 4.4.6 --- Discussion and Conclusion of CSI on Patients --- p.81 / Chapter Chapter 5: --- "Summary, conclusion and future studies" --- p.87 / Chapter 5.1 --- Summary --- p.87 / Chapter 5.2 --- Conclusion --- p.89 / Chapter 5.3 --- Future Studies --- p.89 / References --- p.90 / Publications --- p.104